TORONTO, ONTARIO–(Marketwired – March 28, 2017) –
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Emblem Corp. (the “Company“) (TSX VENTURE:EMC) is pleased to announce the appointment of Spinnaker Capital Markets Inc. (“Spinnaker”) as its capital markets and investor relations advisor.
Spinnaker’s mandate will focus on developing and expanding the network of investors, analysts, and financial intermediaries who are interested in following the Emblem Corp. growth and investment story. The agreement is for an initial term of three months from February 1, 2017 to April 30, 2017, and provides for a full range of investor relations services for a monthly fee of $8,500. The agreement is subject to the acceptance of the TSX Venture Exchange.
Emblem is licensed under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) through its wholly owned subsidiary, Emblem Cannabis Corporation, to cultivate and sell medical cannabis. Emblem carries out its principal activities producing cannabis from its facilities in Paris, Ontario pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Emblem cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Emblem’s control. Such factors include those described in the Company’s Filing Statement dated November 30, 2016 filed with the Canadian Securities Administrators and available on www.sedar.com. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Emblem undertakes no obligation to publicly update or revise forward-looking information.